Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A late-August Office of Human Research Protections (OHRP) public meeting in Washington, D.C. brought debate from researchers, physicians, and patient advocates on the subject of standard of care research and how IRBs should assess risks in randomized trials.

Informed consent, standard of care debated at OHRP meeting